Ferroptosis as a Potential Therapeutic Target for Reducing Inflammation and Corneal Scarring in Bacterial Keratitis
Investigative Opthalmology & Visual Science · 21.02.2024 · 65 (2) · 29
DOI: 10.1167/iovs.65.2.29 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Opthalmology & Visual Science, erschienen am 21.02.2024. Verfasst von Qiankun Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophth…. Hauptthemen laut MEDLINE: Ferroptosis, Keratitis, Eye Infections, Bacterial. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing, China.
Zitieren
APA
Chen, Q., Wang, L., Wei, Y., Xu, X., Guo, X., & Liang, Q. (2024). Ferroptosis as a Potential Therapeutic Target for Reducing Inflammation and Corneal Scarring in Bacterial Keratitis. Investigative Opthalmology & Visual Science, 65(2), 29. https://doi.org/10.1167/iovs.65.2.29
Vancouver
Chen Q, Wang L, Wei Y, Xu X, Guo X, Liang Q. Ferroptosis as a Potential Therapeutic Target for Reducing Inflammation and Corneal Scarring in Bacterial Keratitis. Investigative Opthalmology & Visual Science. 2024;65(2):29. doi:10.1167/iovs.65.2.29
BibTeX
@article{Chen2024,
author = {Chen, Qiankun and Wang, Leying and Wei, Yuan and Xu, Xizhan and Guo, Xiaoyan and Liang, Qingfeng},
title = {Ferroptosis as a Potential Therapeutic Target for Reducing Inflammation and Corneal Scarring in Bacterial Keratitis},
journal = {Investigative Opthalmology & Visual Science},
year = {2024},
volume = {65},
number = {2},
pages = {29},
doi = {10.1167/iovs.65.2.29}
}
EUVIMED